NR4A1 and neoplasm: For example, in a clinical study designed to investigate whether hormonal receptors and HER2 status may be modified throughout tumor progression and therapeutical intervention, it was concluded that these patients experienced changes in the status of hormone receptors and HER2, which could be attributed to adjuvant therapies and may have major impact in survival [72].